JPWO2020247706A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020247706A5
JPWO2020247706A5 JP2021571835A JP2021571835A JPWO2020247706A5 JP WO2020247706 A5 JPWO2020247706 A5 JP WO2020247706A5 JP 2021571835 A JP2021571835 A JP 2021571835A JP 2021571835 A JP2021571835 A JP 2021571835A JP WO2020247706 A5 JPWO2020247706 A5 JP WO2020247706A5
Authority
JP
Japan
Prior art keywords
days
medicament
administered
affected area
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021571835A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535267A (ja
JP2022535267A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036238 external-priority patent/WO2020247706A1/en
Publication of JP2022535267A publication Critical patent/JP2022535267A/ja
Publication of JPWO2020247706A5 publication Critical patent/JPWO2020247706A5/ja
Publication of JP2022535267A5 publication Critical patent/JP2022535267A5/ja
Priority to JP2024199595A priority Critical patent/JP2025032128A/ja
Pending legal-status Critical Current

Links

JP2021571835A 2019-06-05 2020-06-05 乾癬を治療および／または予防する方法 Pending JP2022535267A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024199595A JP2025032128A (ja) 2019-06-05 2024-11-15 乾癬を治療および／または予防する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962857796P 2019-06-05 2019-06-05
US62/857,796 2019-06-05
PCT/US2020/036238 WO2020247706A1 (en) 2019-06-05 2020-06-05 Methods of treating and/or preventing psoriasis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024199595A Division JP2025032128A (ja) 2019-06-05 2024-11-15 乾癬を治療および／または予防する方法

Publications (3)

Publication Number Publication Date
JP2022535267A JP2022535267A (ja) 2022-08-05
JPWO2020247706A5 true JPWO2020247706A5 (https=) 2023-05-25
JP2022535267A5 JP2022535267A5 (https=) 2023-05-25

Family

ID=73653388

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021571835A Pending JP2022535267A (ja) 2019-06-05 2020-06-05 乾癬を治療および／または予防する方法
JP2024199595A Pending JP2025032128A (ja) 2019-06-05 2024-11-15 乾癬を治療および／または予防する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024199595A Pending JP2025032128A (ja) 2019-06-05 2024-11-15 乾癬を治療および／または予防する方法

Country Status (8)

Country Link
US (1) US20220305021A1 (https=)
EP (1) EP3980021A4 (https=)
JP (2) JP2022535267A (https=)
AU (1) AU2020288640A1 (https=)
CA (1) CA3142477A1 (https=)
IL (1) IL288524A (https=)
TW (1) TW202112379A (https=)
WO (1) WO2020247706A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939529B2 (en) * 2007-05-17 2011-05-10 Kinex Pharmaceuticals, Llc Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
US7935697B2 (en) * 2006-12-28 2011-05-03 Kinex Pharmaceuticals, Llc Compositions for modulating a kinase cascade and methods of use thereof
WO2015054500A2 (en) * 2013-10-09 2015-04-16 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
CA2969090C (en) * 2014-12-23 2023-05-02 Novartis Ag Triazolopyrimidine compounds and uses thereof
RU2017134379A (ru) * 2015-03-25 2019-04-03 Новартис Аг Формилированные n-гетероциклические производные в качестве ингибиторов fgfr4
CN118384166A (zh) * 2016-08-12 2024-07-26 阿西纳斯公司 用于调节激酶级联的联芳组合物和方法
WO2018165647A1 (en) * 2017-03-10 2018-09-13 Athenex, Inc. Methods of treating and/or preventing actinic keratosis

Similar Documents

Publication Publication Date Title
JP2023041862A5 (https=)
JP2025186241A5 (https=)
US6265393B1 (en) Prevention of endometriosis signs or symptons
US8647665B2 (en) Methods of treating hot flashes with formulations for transdermal or transmucosal application
JP2020510042A5 (https=)
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
WO1999009964A2 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektion
Hay et al. Short course ketoconazole therapy in pityriasis versicolor
Schutz et al. Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat
JP2021532155A5 (https=)
US5242949A (en) Treating classic migraine
US5331012A (en) Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
JPWO2020247706A5 (https=)
IL320111A (en) Cnp compounds
Uusitalo Long Term Efficacy of a Controlled-Release Formulation of Isosorbide 5-Mononitrate (Imdur®) in Angina Patients Receivingβ-Blockers
Stübner et al. Efficacy and Safety of an Oral Formulation of Cetirizine and Prolonged-release Pseudoephedrine versus Xylometazolin Nasal Spray in Nasal Congestion
Bruun et al. The effect of buserelin versus conventional antiandrogenic treatment in patients with T2-4NxM1 prostatic cancer: A prospective, randomized multicentre phase III trial
US4039684A (en) Method for treatment of canine seborrhea
CA2130770A1 (en) Treatment of upper respiratory tract infections
US20060047007A1 (en) Method for treating urinary disorders
US20130045287A1 (en) Treatment for Concussion using Gallium Compounds
KR20230047412A (ko) 진통 가려움 완화 약학 조성물 및 그 응용 방법
US5498636A (en) Treatment of angina pectoris
AU2015305430A1 (en) Method for treating hyperhidrosis
CN111821423A (zh) 一种白介素2用于治疗慢性自发性荨麻疹的应用